BIOTRICITY INC
For the period ended Mar 31, 2024. Filed Jun 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The following table presents the fees for professional audit services for the fiscal years ended March 31, 2024 and March 31, 2023.
| Fee Category | 2024 | 2023 |
|---|---|---|
| Audit Fees (1) | $155,377 | $145,733 |
| Audit-Related Fees (2) | ||
| Tax Fees | ||
| All Other Fees | ||
| Total Fees | $155,377 | $145,733 |
| (1) | Audit fees consist of audit and review services, consents and review of documents filed with the SEC. |
| (2) | Audit-related fees consists of fees for professional services rendered in connection with the Company’s registration statements and offerings. |
Pre-Approval Policies and Procedures
In its capacity, the Board pre-approves all audit (including audit-related) and permitted non-audit services to be performed by the independent auditors. The Board will annually approve the scope and fee estimates for the year-end audit to be performed by the Company’s independent auditors for the fiscal year. With respect to other permitted services, the Board pre-approves specific engagements, projects and categories of services on a fiscal year basis, subject to individual project and annual maximums. To date, the Company has not engaged its auditors to perform any non-audit related services.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.